Differential gene expression in leukemia is driven by enhancer heterogeneity [TOPmentation]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 80 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 80 samples: 66 distinct titles, 12 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patientsBlood · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE283173_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1192277 and SRA study SRP548413. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 80 sample titles: 66 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8657137 chALL1 H3K27ac
- GSM8657138 chALL1 H3K4me1
- GSM8657139 chALL1 H3K4me3
- GSM8657140 chALL1 H3K79me2
- GSM8657141 chALL1 KMT2A-N
- GSM8657142 chALL2 H3K27ac
- GSM8657143 chALL2 H3K4me1
- GSM8657144 chALL2 H3K4me3
- GSM8657145 chALL2 H3K79me2
- GSM8657146 chALL2 KMT2A-N
- GSM8657147 chALL3 H3K79me2
- GSM8657148 chALL3 RUNX1
- GSM8657149 chALL3 KMT2A-N
- GSM8657150 chALL3 PAF1c
- GSM8657151 chALL3 H3K27ac
- GSM8657152 chALL3 H3K4me1
- GSM8657153 chALL3 H3K4me3
- GSM8657154 chALL3 H3K27me3
- GSM8657155 chALL4 PAF1
- GSM8657156 chALL4 H3K79me2
- GSM8657157 chALL4 SSRP1
- GSM8657158 chALL4 RUNX1
- GSM8657159 chALL4 RING1B
- GSM8657160 chALL4 KMT2A-N
- GSM8657161 chALL4 H3K4me1
- GSM8657162 chALL4 H3K27me3
- GSM8657163 chALL4 H3K27ac
- GSM8657164 chALL4 MLLT1
- GSM8657165 chALL4 H3K4me3
- GSM8657166 chALL4 AFF1-C
- GSM8657167 chALL7 H3K27ac
- GSM8657168 chALL7 H3K4me1
- GSM8657169 chALL7 H3K4me3
- GSM8657170 chALL7 H3K79me3
- GSM8657171 iALL2 RUNX1
- GSM8657172 iALL2 H3K4me3
- GSM8657173 iALL2 H3K27ac
- GSM8657174 iALL2 H3K79me2
- GSM8657175 iALL2 H3K4me1
- GSM8657176 iALL2 H3K27me3
+ 40 more — browse all 80 samples with per-sample file links →
- GSE270503 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [Cut&Run] 56 samples shares heterogeneity, differential
- GSE244446 Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13) [ACT-Seq] 32 samples shares leukemia, enhancer
- GSE244275 Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13) [4C-Seq] 10 samples shares leukemia, enhancer
- GSE126044 Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer 16 samples shares differential, enhancer
- GSE278751 A stem cell model identifies two alternative cell fates in CBFA2T3::GLIS2-driven acute megakaryoblastic leukemia initiation (Multiome scRNA-seq/scATAC-seq) 14 samples shares leukemia, driven
- GSE273054 Differential chromatin accessibility analysis elucidates mechanisms of coronary artery disease-associated genetic variation 119 samples shares differential
- GSE268580 Highly multiplexed single cell chromatin regulator and accessibility profiling elucidates chromatin dynamics in human B cell development and oncogenesis, and reveals an adverse prognostic gene expression signature in B lymphoblastic leukemias 15 samples shares leukemia
- GSE289467 Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer [CUT&Tag] 50 samples shares heterogeneity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.